Macquarie Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
RIM
GCM
CRM
Macquarie Group's LMAT Position: Q3 2022 in Review
Macquarie Group sold out of LeMaitre Vascular (LMAT) in Q3 2022, closing a stake of 3,987 shares — an estimated $182K sold.
Macquarie Group first reported a position in LMAT in Q1 2016 and held it in 4 quarters. The position peaked at $182K in Q2 2022. 189 funds tracked by Wall St. Rank hold LMAT as of Q3 2022.
- Macquarie Group reported no remaining LeMaitre Vascular position as of Q3 2022 after selling out during the quarter.
- Macquarie Group sold 3,987 LeMaitre Vascular shares in Q3 2022, an estimated $182K.
- Macquarie Group first reported a position in LeMaitre Vascular in Q1 2016 and held it in 4 quarters.
- Macquarie Group's LeMaitre Vascular position peaked at $182K in Q2 2022.
- 189 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2022.
Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.